Remove 2024 Remove Packaging Remove Vaccines
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Credit: viewimage/Shutterstock.

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines 407
article thumbnail

ICH Q6B for Analytics

PharmTech

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. With their technical and methodological improvements, advanced techniques provide valuable information on overall product mass profiles.

Dosage 52
article thumbnail

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

2024 ESC guidelines for the management of elevated blood pressure and hypertension. doi:10.1016/20S0140-6736(22)02034-7 Aprocitentan (Tryvio) package insert. Widaplik (telmisartan, amlodipine, indapamide) package insert. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 Eur Heart J. 2018; 39: 3021–3104.

article thumbnail

3 of the year’s most notable FDA nods

PharmaVoice

FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record high for the first part of the year, according to Clarivate. A long-time leader in vaccines, the U.K.

FDA 130
article thumbnail

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives.